Trademark: 79261592
Word
MAYZENT
Status Date
Tuesday, March 17, 2020
Registration Number
6010378
Registration Date
Tuesday, March 17, 2020
Filing Date
Friday, May 3, 2019
Published for Opposition
Tuesday, December 31, 2019
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
The color(s) orange, red, violet and blue is/are claimed as a feature of the mark.
The mark consists of the word "MAYZENT" preceded by an oval, divided by five lines forming arches of differing heights, around a single line, emanating from the bottom-left of the oval. The word "MAYZENT" is orange and the arches from right to left are in the colors orange, red, violet and blue with the single line also in blue. The color white represents transparent areas and is not a feature of the mark.
Aug 7, 2020
Final Decision Transaction Processed By Ib
Jul 23, 2020
Final Disposition Notice Sent To Ib
Jul 23, 2020
Final Disposition Processed
Jun 17, 2020
Final Disposition Notice Created, To Be Sent To Ib
Mar 17, 2020
Registered-Principal Register
Jan 4, 2020
Notification Processed By Ib
Dec 31, 2019
Official Gazette Publication Confirmation E-Mailed
Dec 31, 2019
Published For Opposition
Dec 18, 2019
Notification Of Possible Opposition Sent To Ib
Dec 18, 2019
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Dec 11, 2019
Notification Of Notice Of Publication E-Mailed
Nov 23, 2019
Approved For Pub - Principal Register
Sep 6, 2019
Refusal Processed By Ib
Aug 19, 2019
Non-Final Action Mailed - Refusal Sent To Ib
Aug 19, 2019
Teas/Email Correspondence Entered
Aug 19, 2019
Correspondence Received In Law Office
Aug 19, 2019
Refusal Processed By Mpu
Aug 19, 2019
Teas Response To Office Action Received
Aug 8, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 8, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 28, 2019
Non-Final Action (Ib Refusal) Prepared For Review
Jul 27, 2019
Non-Final Action Written
Jul 23, 2019
Application Filing Receipt Mailed
Jul 18, 2019
Assigned To Examiner
Jul 18, 2019
New Application Office Supplied Data Entered In Tram
Jul 8, 2019
Limitation From Original Application Entered
Jun 27, 2019
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
